Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endometrial Carcinoma
|
326 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.030 | 3 | 2007 | 2012 | |||||
Malignant neoplasm of endometrium
|
197 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.030 | 3 | 2007 | 2012 | |||||
Head and Neck Carcinoma
|
118 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.020 | 2 | 2008 | 2013 | |||||
Malignant Head and Neck Neoplasm
|
118 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.020 | 2 | 2008 | 2013 | |||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.010 | 1 | 2015 | 2015 | |||||
Periodontitis
|
116 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.010 | 1 | 2019 | 2019 | |||||
Renal Cell Carcinoma
|
288 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.010 | 1 | 2015 | 2015 | |||||
Lip and Oral Cavity Carcinoma
|
172 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.030 | 0.333 | 3 | 2012 | 2015 | ||||
Malignant neoplasm of mouth
|
184 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.030 | 0.333 | 3 | 2012 | 2015 | ||||
Polycystic Ovary Syndrome
|
363 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.030 | 0.333 | 3 | 2009 | 2014 | ||||
Gallbladder Carcinoma
|
75 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.040 | 0.500 | 4 | 2007 | 2014 | ||||
Malignant neoplasm of gallbladder
|
81 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.030 | 0.667 | 3 | 2007 | 2014 | ||||
Stage 0 Gallbladder Cancer AJCC v8
|
56 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.030 | 0.667 | 3 | 2007 | 2014 | ||||
Stage IIA Gallbladder Cancer AJCC v8
|
56 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.030 | 0.667 | 3 | 2007 | 2014 | ||||
Stage IIB Gallbladder Cancer AJCC v8
|
56 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.030 | 0.667 | 3 | 2007 | 2014 | ||||
Stage III Gallbladder Cancer AJCC v8
|
56 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.030 | 0.667 | 3 | 2007 | 2014 | ||||
Stage IV Gallbladder Cancer AJCC v8
|
56 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.030 | 0.667 | 3 | 2007 | 2014 | ||||
Carcinoma of lung
|
1204 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.100 | 0.900 | 20 | 1998 | 2017 | ||||
Malignant neoplasm of lung
|
1142 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.100 | 0.900 | 20 | 1998 | 2017 | ||||
Primary malignant neoplasm of lung
|
981 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.100 | 0.900 | 20 | 1998 | 2017 | ||||
cervical cancer
|
268 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.090 | 1.000 | 9 | 2012 | 2018 | ||||
Cervix carcinoma
|
283 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.090 | 1.000 | 9 | 2012 | 2018 | ||||
Malignant tumor of cervix
|
245 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.090 | 1.000 | 9 | 2012 | 2018 | ||||
Breast Carcinoma
|
2793 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.080 | 1.000 | 8 | 2001 | 2016 | ||||
Malignant neoplasm of breast
|
3417 | 0.533 | 0.720 | 15 | 74720644 | missense variant | T/A;C;G | snv | 0.11 | 5.9E-02 | 0.080 | 1.000 | 8 | 2001 | 2016 |